FDA-cleared dental AI that reads X-rays for dentists, DSOs, and insurers
Overjet is an FDA-cleared dental AI platform for dental practices, DSOs, and insurers.
AI Panel Score
6 AI reviews
Reviewed
AI Editor ApprovedApproved and published by our AI Editor-in-Chief after full panel analysis.Overjet is an FDA-cleared dental AI platform that analyzes X-rays and automates administrative work for dental practices, multi-location DSOs, and dental insurers. It is built for clinicians who want objective diagnostics and for payers running utilization review and network management. Pricing is quote-based: Overjet is sales-led with no public rates, so practices contact the vendor for a custom quote. Its Vision AI detects and outlines caries, calculus, bone levels, and periapical radiolucencies, with color overlays that measure bone loss; IRIS provides AI-native imaging with FDA-cleared image enhancement; Overjet Voice is an ambient scribe that writes clinical notes and perio charts in English and Spanish; and Insurance Verification returns code-level coverage days before appointments. It is the first dental AI cleared for both caries detection and bone-level measurement, and it fits DSOs and insurers at scale. Alternatives include Pearl, VideaHealth, Diagnocat, and Denti.AI.
Overjet layers AI directly onto dental radiographs. As X-rays are captured, its Vision AI detects and outlines disease and anatomy such as caries, calculus, bone levels, and periapical radiolucencies, and applies color overlays that show the exact severity of periodontal bone loss, so clinicians can show patients what they see and explain recommended treatment. Providers report an average 27% increase in case acceptance from this patient-education view.
IRIS is Overjet's AI-native imaging software, with detection built into the viewer rather than bolted onto a separate tool, plus FDA-cleared image enhancement that sharpens blurry or noisy X-rays without losing clinical detail. Overjet Voice is an ambient AI scribe that documents visits and writes hands-free perio charts and referral letters in English and Spanish, syncing into the practice management system. On the revenue side, Insurance Verification confirms eligibility and returns code-level coverage breakdowns days ahead of appointments, ReviewPASS delivers instant claim approvals, and AI Credentialing handles provider data and roster management.
Overjet is built for solo practices, multi-location DSOs (deployed across North American Dental Group and Mortenson Dental Partners), and dental insurers who use it for utilization review and provider network management. Pricing is quote-based through the sales team rather than published, and it typically targets larger implementations. Competitors in the category include Pearl, VideaHealth, Diagnocat, and Denti.AI.
It is the first and only dental AI FDA-cleared for both caries detection and bone-level measurement, integrates natively with practice management systems such as Oryx, and serves payers representing more than 75 million U.S. patients.
Clinical intelligence dashboards that surface performance insights across locations to manage and grow the practice.
Ambient AI scribe that documents visits and drafts clinical notes, perio charts, and referral letters in English and Spanish.
AI-assisted claim review and provider network management for dental insurers.
Analyzes dental X-rays in real time to detect and outline caries, calculus, bone levels, and periapical radiolucencies.
Applies color overlays to radiographs to quantify the exact level of periodontal bone loss.
FDA-cleared enhancement that sharpens blurry or noisy X-rays without losing clinical detail.
AI-native dental imaging software with detection built into the viewer rather than a separate add-on.
Natively integrates AI findings and documentation into practice management systems such as Oryx.
Automatically verifies patient eligibility and returns code-level coverage breakdowns days before appointments.
Delivers instant dental claim approvals without manual review.
End-to-end provider credentialing and data management, including delegated credentialing and roster management.
Generates hands-free periodontal charts from ambient AI during the patient visit.
Pricing requires contacting the vendor.
The only dental AI cleared for both caries and bone loss, priced for enterprises not solos.
“Overjet is the funded, FDA-cleared category leader in dental AI, and the 27% case-acceptance lift makes the ROI legible to any board. The blind spot is quote-based pricing tuned for DSOs, which leaves smaller practices negotiating without a public benchmark.”
Dentists running Overjet's overlays close 27% more treatment plans on average. That's not a software metric. That's chair-side revenue a practice feels every single month. The board understands revenue per chair better than any AI benchmark.
The vendor question answers itself. Overjet raised a $53.2M Series C in 2024 at a $550M valuation, and it's the only dental AI FDA-cleared for both caries detection and bone-level measurement. Pearl pushes hard on imaging, but nobody else holds both clearances.
The catch is procurement. Pricing is quote-based and built for multi-location DSOs, so a solo office negotiates blind against a sales team. Pilot Vision AI in two operatories, track case acceptance for 90 days, then decide whether the enterprise contract earns its keep.
Only dental AI cleared for both caries detection and bone-level measurement versus Pearl and VideaHealth.
FDA clearance and HIPAA compliance lower the risk of deploying AI on patient data.
Native PMS integration shortens rollout, but quote-based onboarding adds sales-cycle delay.
Imaging, documentation, and revenue-cycle modules fit both clinical and payer strategies.
A $53.2M Series C in 2024 at a $550M valuation signals a durable, well-capitalized vendor.
Multi-location DSOs who want measurable case-acceptance gains.
Solo practices who need transparent published pricing.
For a multi-site group, Overjet turns diagnostic consistency into a defensible clinical standard.
“Overjet is the category's strongest clinical bet, pairing dual FDA clearances with an AI-native IRIS viewer that standardizes diagnosis across every chair. The strategic cost is deep PMS lock-in and quote-based pricing, which a standardizing group should treat as the price of consistency.”
Diagnostic variance between two dentists reading the same bitewing is the quiet liability every multi-site group carries. Overjet's Bone Loss Measurement puts a color-coded millimeter reading on the radiograph, which turns a subjective call into a defensible, chartable number across the group.
As a clinical strategy, this is the strongest bet in the category. The IRIS viewer builds detection into imaging rather than sitting beside it, and FDA clearance for both caries and bone loss gives a Chief Dental Officer something Pearl and VideaHealth can't fully match on paper. Serving payers representing 75 million patients means the same engine sits on both sides of the claim.
The tradeoff is lock-in. Once findings, perio charts, and overlays live inside your PMS, the migration cost is real, and pricing stays quote-based. For a group standardizing care across dozens of chairs, though, that depth is the point, not the risk.
First and only dental AI cleared for both caries detection and bone-level measurement.
Purpose-built for dentistry with dual FDA clearances no rival fully matches.
Native PMS integration including Oryx is strong, though quote-based scoping slows planning.
Standardizes care across locations, but deepens dependence on one vendor's overlays.
Coverage spans detection, documentation, revenue cycle, and payer analytics under one clinical engine.
Chief Dental Officers standardizing diagnosis across many locations.
Single-chair practices who want a lightweight second opinion.
No public pricing, but a 27% case-acceptance lift and $133M in funding anchor the math.
“Overjet's pricing is entirely quote-based, so procurement gets no public benchmark and can't model year-three cost independently. The offset is a documented 27% case-acceptance lift plus revenue-cycle automation, which gives the spend a real payback story.”
A 27% lift in case acceptance is the number that pays for this. The price that offsets it isn't published. Overjet quotes by practice size and module count, so the invoice starts as a sales call.
The viability math is easy. Overjet raised $53.2M in 2024 and holds roughly $133M total, so the vendor isn't a runway risk. Pearl prices the same way, quote-based with no public tiers, so opacity is a category norm, not an Overjet quirk.
The catch is predictability. With no published overage or per-module rate, a growing DSO can't model year-three cost without the sales team. ReviewPASS and Insurance Verification should recover staff hours on the revenue-cycle side. Real payback, unpredictable sticker.
Native PMS billing integration helps, but sales-led quoting slows procurement.
Enterprise-style contracts are implied by the DSO focus, though terms aren't public.
Pricing is quote-based with no published tiers or overage rates.
A 27% average case-acceptance lift is a concrete, chair-level return.
Module-based scoping makes all-in cost hard to model before a sales call.
Finance leads who can evaluate ROI without published pricing.
Small practices who need a fixed monthly rate.
The AI outlines caries chairside and writes the perio chart, so your evening notes shrink.
“For a working dentist, the value is chairside: Vision AI outlines disease while the patient watches, and Overjet Voice writes the perio chart hands-free into the PMS. The overlays are persuasive enough that clinical judgment still has to sit on top of them.”
The bitewing loads on the operatory monitor and the caries is already outlined before the chair swings around. That's the win Vision AI actually delivers, not a report you read later, but a picture the patient sees while they're still numb and listening.
Where it earns its keep daily is charting. Overjet Voice writes the perio chart hands-free while you probe, in English or Spanish, and drops it back into the PMS instead of a second data-entry pass at 5pm. Diagnocat does solid detection too, but the ambient documentation is where a chairside day gets its time back.
The friction is the color overlay itself. Patients read red-for-bone-loss instantly, but a nervous clinician can over-explain a false positive and talk themselves into treatment the film didn't earn. The 27% case-acceptance number cuts both ways, and it stays a documentation tool that needs your judgment on top.
Real-time overlays and ambient charting hold up in an actual operatory flow.
Overjet Voice charts hands-free in English and Spanish, though voice accuracy is unproven here.
Persuasive overlays can nudge over-treatment without clinician discipline.
Detection, enhancement, perio charting, and referrals cover a deep clinical range.
Findings and notes drop back into the PMS without a second entry pass.
Dentists who want disease findings and charting done chairside.
Clinicians who distrust AI-flagged findings on their radiographs.
The red-on-the-X-ray trick sells treatment better than any dentist's speech ever could.
“The color overlays make Overjet unusually persuasive at the chair, and the IRIS viewer feels like real software, not a science project. The frustration is the wall of quote-based pricing that clearly isn't built for the small, curious practice.”
The thing that actually lands isn't the AI. It's the color. Red on the X-ray means bone loss, and suddenly a patient who tuned out every past explanation gets why the deep cleaning matters. That's the whole 27% case-acceptance story in one glance.
Under the hood the polish looks real. IRIS puts detection right in the viewer instead of a separate window, and the enhancement actually cleans up the grainy sensor shots every office has. It's FDA-cleared, HIPAA-compliant, and backed by $133M, so this isn't a weekend project that vanishes next year.
The catch is you'll never see a price. Pearl at least competes openly, but both hide behind a sales call, and this one clearly wants big multi-location groups, not the solo office curious enough to try it. Mobile's listed for iOS and Android, but nobody's buying dental AI to read bitewings on a phone.
Color overlays and in-viewer detection feel deliberately designed for real chairs.
Detection appears automatically, so most of the value needs little training.
iOS and Android are listed, though bitewing reading stays a desktop task.
Native PMS integration eases setup, but a quote-based sales gate slows getting started.
FDA-cleared and HIPAA-compliant technology backed by $133M in funding.
Practices who want patients to visibly understand their diagnosis.
Curious solo dentists who want to try before committing.
Dual FDA clearances and $133M make this hard to dismiss, but the exit door is narrow.
“Overjet clears the bar most dental-AI pitches fail: real FDA clearances, $133M raised, and named DSO customers instead of anonymous logos. The reservation is exit portability, since the overlays and charts embed in your PMS and pricing stays quote-only.”
FDA clearance is the one thing in this category you can't fake with a slick demo. Overjet's Vision AI holds it for both caries detection and bone-level measurement, the only vendor that does. That's a real moat, not a slogan.
The tells are mild. 'World-leader in dental AI' is the kind of superlative I'd normally discount, but $133M raised and a $550M valuation put weight behind it. Named DSO deployments, North American Dental Group and Mortenson, beat the usual anonymous logo wall.
The yellow flag is exit. Overlays, perio charts, and findings live inside your PMS through Overjet's own engine, so leaving means unwinding all of it. Pricing's quote-only, so you can't compare against Pearl or VideaHealth without two sales calls. Strong hand. Just know the door only swings one way.
Only dental AI cleared for both caries detection and bone-level measurement.
Overlays and charts embed in the PMS, making migration costly.
$133M raised at a $550M valuation signals staying power.
The 'world-leader' superlative is offset by verifiable FDA clearances and funding.
Named DSO deployments and payer coverage back the marketing claims.
Groups who want proven, FDA-cleared dental AI.
Buyers who need an easy exit path later.
Common questions answered by our AI research team
Overjet uses custom, quote-based pricing set by practice size and the modules you choose, so there are no public rates. Plans typically bundle Vision AI, IRIS imaging, and support, and are quoted by the sales team, often geared toward multi-location DSOs.
Yes. Overjet's Vision AI analyzes radiographs in real time to detect and outline caries, calculus, and periapical radiolucencies, with color overlays that quantify periodontal bone loss. It is FDA-cleared for both caries detection and bone-level measurement.
Overjet integrates natively into practice management systems, including Oryx, so AI findings, charts, and documentation appear inside your existing workflow. Overjet Voice writes clinical notes and perio charts directly back into the PMS.
Yes. Overjet is HIPAA compliant and built on FDA-cleared technology, and it is used by insurers representing more than 75 million U.S. patients. For payers it also supports utilization review and provider network management.
Yes. Insurance Verification automatically confirms eligibility and returns code-level coverage breakdowns days before appointments, while ReviewPASS delivers instant claim approvals without manual review. AI Credentialing manages provider data and rosters.
Overjet builds FDA-cleared dental AI that reads X-rays and automates insurance and administrative work for dental practices, DSOs, and insurers. Based in Boston.
